Onconetix, Inc. Common Stock
$0.64
Market Cap
$2.80M
Shares Outstanding
4.4M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Feb 18, 2022
Round Lot
100
Locale
US
Day Open
$0.67
Day High
$0.68
Day Low
$0.64
Volume
171.6K
VWAP
$0.65
Prev Close
$0.66
Transactions
--
Acc. Volume
--
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.
Onconetix, Inc. Common Stock (ONCO) closed the 2026-09-18 session at $0.64, down 3.69% versus the previous close (-0.02). The stock opened at $0.67 and traded between $0.64 and $0.68 during that session. Session trading volume was 172K shares. The volume-weighted average price (VWAP) is $0.65.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.
Onconetix, Inc. Common Stock has a market capitalization of $2.8 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. ONCO is listed on the XNAS exchange. The company employs approximately 2 people. Onconetix, Inc. Common Stock is headquartered in CINCINNATI, OH. The recorded listing date is 2022-02-18.
On this page you can find market ONCO stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.